GL1X · GenesisL1 explorer

UniProt P17752

Tryptophan 5-hydroxylase 1 (P17752)

Tryptophan 5-hydroxylase 1 (UniProt P17752), EC 1.14.16.4: 27 experimental structures and 1 predicted model on GenesisL1, 22 ligands bound, 57 pockets. Binding sites, druggability and experiment against prediction (TM-score) in…

UniProt
P17752
Protein
Tryptophan 5-hydroxylase 1
EC
1.14.16.4
Experimental structures
27
Predicted models
1
Ligands
22
Pockets
57 · 28 records with a druggable one

Structures

28 records of P17752 in the MolNFT archive: 27 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
1MLWCrystal structure of human tryptophan hydroxylase with bound 7,8-dihydro-L-biopterin cofactor and…x-ray diffractionAFE, HBI2 (best 0.72)
1MLWCrystal structure of human tryptophan hydroxylase with bound 7,8-dihydro-L-biopterin cofactor and…x-ray diffractionAFE, HBI2 (best 0.72)
3HF6Crystal structure of human tryptophan hydroxylase type 1 with bound LP-521834 and FEx-ray diffractionAFE, LX03 (best 0.75)
3HF6Crystal structure of human tryptophan hydroxylase type 1 with bound lp-521834 and fex-ray diffractionAFE, LX03 (best 0.75)
3HF8Crystal structure of human tryoptophan hydroxylase type 1 with bound LP-533401 and Fex-ray diffractionAFE, ML02 (best 0.74)
3HF8Crystal structure of human tryoptophan hydroxylase type 1 with bound lp-533401 and fex-ray diffractionAFE, ML02 (best 0.74)
3HFBCrystal structure of human tryoptophan hydroxylase type 1 with LP-534193x-ray diffractionAFE, ML42 (best 0.76)
3HFBCrystal structure of human tryoptophan hydroxylase type 1 with lp- 534193x-ray diffractionAFE, ML42 (best 0.76)
5J6DDiscovery of acyl guanidine tryptophan hydroxylase-1 inhibitorsx-ray diffractionA, BFE, 6H55 (best 0.82)
5J6DDiscovery of acyl guanidine tryptophan hydroxylase-1 inhibitorsx-ray diffractionA, BFE, 6H55 (best 0.82)
5L01Tryptophan 5-hydroxylase in complex with inhibitor (3~{S})-8-[2-azanyl-6-[(1~{R})-1-(4-chloranyl-2-p…x-ray diffractionAFE, 6Z42 (best 0.76)
5L01Tryptophan 5-hydroxylase in complex with inhibitor (3~{S})-8-[2…x-ray diffractionAFE, 6Z42 (best 0.76)
5TPGOptimization of spirocyclic proline tryptophanhydroxylase-1 inhibitorsx-ray diffractionAFE, CCN, 7H52 (best 0.75)
5TPGOptimization of spirocyclic proline tryptophanhydroxylase-1 inhibitorsx-ray diffractionAFE, CCN, 7H52 (best 0.75)
7ZIFCrystal structure of human tryptophan hydroxylase 1 in complex with inhibitor KM-480x-ray diffractionAFE, IWA1 (best 0.77)
7ZIGCrystal structure of human tryptophan hydroxylase 1 in complex with inhibitor KM-05-060x-ray diffractionAIVZ, FE1 (best 0.74)
7ZIHCrystal structure of human tryptophan hydroxylase 1 in complex with inhibitor AG-01-128x-ray diffractionAFE, JCR1 (best 0.73)
7ZIICrystal structure of human tryptophan hydroxylase 1 in complex with inhibitor KM-05-193x-ray diffractionAFE, IVQ1 (best 0.73)
7ZIJCrystal structure of human tryptophan hydroxylase 1 in complex with inhibitor KM-05-080x-ray diffractionAIVW, FE1 (best 0.72)
7ZIKCrystal structure of human tryptophan hydroxylase 1 in complex with inhibitor LP778902x-ray diffractionA, BFE, IVN3 (best 0.74)
8CJICrystal structure of human tryptophan hydroxylase 1 in complex with inhibitor KM-07-052x-ray diffractionAFE, UWC1 (best 0.74)
8CJJCrystal structure of human tryptophan hydroxylase 1 in complex with inhibitor KM-06-057x-ray diffractionAFE, UVF1 (best 0.74)
8CJKCrystal structure of human tryptophan hydroxylase 1 in complex with inhibitor KM-06-098x-ray diffractionAFE, UVU1 (best 0.76)
8CJLCrystal structure of human tryptophan hydroxylase 1 in complex with inhibitor TPT-004x-ray diffractionAFE, UXC1 (best 0.73)
8CJMCrystal structure of human tryptophan hydroxylase 1 in complex with inhibitor KM-07-047x-ray diffractionAFE, UXL1 (best 0.76)
8CJNCrystal structure of human tryptophan hydroxylase 1 in complex with inhibitor KM-06-070x-ray diffractionAFE, UX31 (best 0.74)
8CJOCrystal structure of human tryptophan hydroxylase 1 in complex with inhibitor KM-06-004x-ray diffractionAFE, UWL2 (best 0.70)
P17752AlphaFold monomer V2.0 prediction for tryptophan 5-hydroxylase 1 (P17752)predictedA—5 (best 0.79)

Ligands

  • FE · Fe (III) ion · in 27 records
  • 6H5 · 4-[(N-{[2-(3-methoxyphenoxy)-6-(piperidin-1-yl)phenyl]methyl}carbamimidoyl)carbamoyl]-L-phenylalanine · in 2 records
  • 6Z4 · (3~{S})-8-[2-azanyl-6-[(1~{R})-1-(4-chloranyl-2-phenyl-phenyl)-2,2,2-tris(fluoranyl)ethoxy]pyrimidin-4-yl]-2,8-diazaspiro[4.5]decane-3-carboxylic acid · in 2 records
  • 7H5 · (3S)-8-(2-amino-6-{(1R)-1-[5-chloro-3'-(methylsulfonyl)[1,1'-biphenyl]-2-yl]-2,2,2-trifluoroethoxy}pyrimidin-4-yl)-2,8-diazaspiro[4.5]decane-3-carboxylic acid · in 2 records
  • CCN · Acetonitrile · in 2 records
  • HBI · 7,8-dihydrobiopterin · in 2 records
  • LX0 · 4-(4-amino-6-{[(1R)-1-naphthalen-2-ylethyl]amino}-1,3,5-triazin-2-yl)-L-phenylalanine · in 2 records
  • ML0 · 4-{2-amino-6-[(1R)-2,2,2-trifluoro-1-(3'-fluorobiphenyl-4-yl)ethoxy]pyrimidin-4-yl}-L-phenylalanine · in 2 records
  • ML4 · 4-(5-{[(2'-methylbiphenyl-2-yl)methyl]amino}pyrazin-2-yl)-L-phenylalanine · in 2 records
  • IVN · (2~{R})-2-azanyl-3-[4-[2-azanyl-6-[(1~{R})-1-[4-chloranyl-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-tris(fluoranyl)ethoxy]pyrimidin-4-yl]phenyl]propanoic acid · in 1 record
  • IVQ · 8-(5~{H}-[1,3]dioxolo[4,5-f]benzimidazol-6-ylmethyl)-7-(phenylmethyl)-3-propyl-purine-2,6-dione · in 1 record
  • IVW · 8-(1~{H}-benzimidazol-2-ylmethyl)-3-cyclopropyl-7-(phenylmethyl)purine-2,6-dione · in 1 record
  • IVZ · (2~{R})-2-azanyl-5-[[2-[[3-methyl-2,6-bis(oxidanylidene)-7-(phenylmethyl)purin-8-yl]methyl]-1~{H}-benzimidazol-5-yl]amino]-5-oxidanylidene-pentanoic acid · in 1 record
  • IWA · (2R)-2-azanyl-5-[[2-[3-methyl-2,6-bis(oxidanylidene)-7-(phenylmethyl)purin-8-yl]sulfanyl-3H-benzimidazol-5-yl]amino]-5-oxidanylidene-pentanoic acid · in 1 record
  • JCR · 8-(1~{H}-benzimidazol-2-ylmethyl)-3-ethyl-7-(phenylmethyl)purine-2,6-dione · in 1 record
  • UVF · 3-ethyl-7-(phenylmethyl)-8-(5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-ylmethyl)purine-2,6-dione · in 1 record
  • UVU · 3-ethyl-8-[(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)methyl]-7-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]purine-2,6-dione · in 1 record
  • UWC · methyl (2~{S})-2-azanyl-3-[[3-[[3-ethyl-2,6-bis(oxidanylidene)-8-(5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-ylmethyl)purin-7-yl]methyl]phenyl]carbonylamino]propanoate · in 1 record
  • UWL · 1-[(3~{S})-3-(4-chloranyl-2-fluoranyl-phenyl)-1,4,8-triazatricyclo[7.4.0.0^{2,7}]trideca-2(7),8-dien-4-yl]-2-(2-ethyl-6-methyl-pyridin-3-yl)oxy-ethanone · in 1 record
  • UX3 · 3-ethyl-7-[(4-phenylphenyl)methyl]-8-(5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-ylmethyl)purine-2,6-dione · in 1 record
  • UXC · 3-ethyl-8-[(2-methyl-5~{H}-imidazo[2,1-b][1,3]thiazol-6-yl)methyl]-7-(oxetan-3-ylmethyl)purine-2,6-dione · in 1 record
  • UXL · 7-(cyclobutylmethyl)-3-ethyl-8-(5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-2-ylmethyl)purine-2,6-dione · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.